Reduction in GABAB on glia induce Alzheimer’s disease related changes
Brain, Behavior, and Immunity · 2023
DOI: 10.1016/j.bbi.2023.03.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2023. Verfasst von Amanda M Leisgang Osse und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Nevada, Las Vegas, Department of Brain Health, 4505 S. Maryland Parkway, Las Vegas, NV 89154, United States. Electronic address: amanda…. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's Disease (AD) is a neurodegenerative disorder characterized by beta-amyloid plaques (Aβ), neurofibrillary tangles (NFT), and neuroinflammation. Data have demonstrated that neuroinflammation contributes to Aβ and NFT onset and progression, indicating inflammation and glial signaling is vital to understanding AD. A previous investigation demonstrated a significant decrease of the GABAB receptor (GABABR) in APP/PS1 mice (Salazar et al., 2021). To determine if changes in GABABR restricted to glia serve a role in AD, we developed a mouse model with a reduction of GABABR restricted to macrophages, GAB/CX3ert. This model exhibits changes in gene expression and electrophysiological alterations similar to amyloid mouse models of AD. Crossing the GAB/CX3ert mouse with APP/PS1 resulted in significant increases in Aβ pathology. Our data demonstrates that decreased GABABR on macrophages leads to several changes observed in AD mouse models, as well as exacerbation of AD pathology when crossed with existing models. These data suggest a novel mechanism in AD pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Nevada, Las Vegas, Department of Brain Health, 4505 S. Maryland Parkway, Las Vegas, NV 89154, United States. Electronic address: amanda.leisgang@unlv.edu.
- The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, United States.
- University of Nevada, Las Vegas, Department of Psychology, 4505 S. Maryland Parkway, Las Vegas, NV 89154, United States.
- University of Nevada, Las Vegas, Department of Brain Health, 4505 S. Maryland Parkway, Las Vegas, NV 89154, United States.
- Indiana University, School of Medicine, 340 W 10(th) Street, Indianapolis, IN 46202, United States.
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Osse, A. M. L., Pandey, R. S., Wirt, R. A., Ortiz, A. A., Salazar, A., Kimmich, M., Toledano Strom, E. N., Oblak, A., Lamb, B., Hyman, J. M., Carter, G. W., & Kinney, J. (2023). Reduction in GABAB on glia induce Alzheimer’s disease related changes. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2023.03.002
Vancouver
Osse AML, Pandey RS, Wirt RA, Ortiz AA, Salazar A, Kimmich M, et al. Reduction in GABAB on glia induce Alzheimer’s disease related changes. Brain, Behavior, and Immunity. 2023. doi:10.1016/j.bbi.2023.03.002
BibTeX
@article{Osse2023,
author = {Osse, Amanda M Leisgang and Pandey, Ravi S and Wirt, Ryan A and Ortiz, Andrew A and Salazar, Arnold and Kimmich, Michael and Toledano Strom, Erin N and Oblak, Adrian and Lamb, Bruce and Hyman, James M and Carter, Gregory W and Kinney, Jefferson},
title = {Reduction in GABAB on glia induce Alzheimer’s disease related changes},
journal = {Brain, Behavior, and Immunity},
year = {2023},
doi = {10.1016/j.bbi.2023.03.002}
}
EUVIMED